Miller N S
Department of Psychiatry, University of Illinois at Chicago 60612, USA.
J Addict Dis. 1995;14(1):23-46. doi: 10.1300/J069v14n01_04.
This review categorizes five main uses of pharmacologic agents in the treatment of alcoholism: reversing the active pharmacologic effects of alcohol; controlling withdrawal symptoms; blocking the desire for alcohol use; treating psychiatric symptoms induced by alcohol and other drugs; and treating independent, but concurrent, psychopathologic conditions. No medication, including stimulants such as caffeine, has been found to actually reverse the action of alcohol. Because of their cross-tolerance and dependence with alcohol, benzodiazepines--especially intermediate acting preparations such as chlordiazepoxide and diazepam--are the mainstay in treating alcohol withdrawal, including convulsions and delirium tremens. Studies suggest that serotonin uptake inhibitors such as zimelidine, citalopram, viqualine, and fluoxetine may reduce alcohol consumption and that is not an antidepressant effect. Naltrexone, an opioid antagonist, also may be effective in reducing the urge to drink. The major aversive agent to alcohol in clinical use is disulfiram. When an independent psychiatric disorder accompanies alcoholism or drug addiction, it may require treatment, including pharmacotherapy, as the addiction is also being treated with nonpharmacologic methods such as abstinence-based treatment programs.
逆转酒精的活性药理作用;控制戒断症状;阻断对酒精使用的渴望;治疗由酒精和其他药物引起的精神症状;以及治疗独立但并发的精神病理状况。尚未发现包括咖啡因等兴奋剂在内的任何药物能真正逆转酒精的作用。由于苯二氮䓬类药物与酒精存在交叉耐受性和依赖性,尤其是氯氮卓和地西泮等中效制剂,是治疗酒精戒断(包括惊厥和震颤谵妄)的主要药物。研究表明,齐美利定、西酞普兰、维喹啉和氟西汀等5-羟色胺摄取抑制剂可能会减少酒精摄入量,且这并非抗抑郁作用。阿片类拮抗剂纳曲酮也可能有效降低饮酒冲动。临床使用的主要酒精厌恶剂是双硫仑。当独立的精神障碍伴随酒精中毒或药物成瘾时,可能需要进行治疗,包括药物治疗,因为成瘾也正在通过基于戒酒的治疗项目等非药物方法进行治疗。